Nos publications > > Articles > > 2007-2015 > 2014

Stroke Prevention in Patients with Atrial Fibrillation in France : Comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran and rivaroxaban), warfarin and aspirin

Lanitis T, Cotté F, Gaudin A, Kachaner I, Kongnakorn T, Durand-Zaleski I

Journal of Medical Economics. 2014 May 15

Dernière mise à jour le 28/10/2015